Clinical trial
COVID-19 Antibody Responses in Cystic Fibrosis (CAR-CF)
NCT05217784 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19 Antibody Responses in Cystic Fibrosis (CAR-CF)
- Lead sponsor
- Rabin Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 25, 2022
- Completion date
- January 31, 2024
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, cystic fibrosis